Paper8552381
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.
Rochefort P and 8 others. Oncogene, 1996. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Papers, record 8552381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8552381
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Papillary | Major topic |
| Genes, ras | Major topic |
| Promoter Regions, Genetic | Major topic |
| Thyroglobulin | Major topic |
| Thyroid Gland | Major topic |
| Thyroid Neoplasms | Major topic |
| Animals | |
| Calcitonin | |
| Cattle | |
| Female | |
| Humans | |
| Hyperplasia | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Mice, Transgenic | |
| Thyroxine |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39874138 | Development of animal models to study aggressive thyroid cancers. | Eur Thyroid J | 2025 | https://conductscience.org/library/papers/39874138 | PubMed |
| 37446316 | Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446316 | PubMed |
| 37260297 | Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37260297 | PubMed |
| 34359686 | Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359686 | PubMed |
| 28361927 | Molecular profiling of thyroid nodule fine-needle aspiration cytology. | Nat Rev Endocrinol | 2017 | https://conductscience.org/library/papers/28361927 | PubMed |
| 26146959 | KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1. | Lab Invest | 2015 | https://conductscience.org/library/papers/26146959 | PubMed |
| 26123589 | Mouse models of thyroid cancer: A 2015 update. | Mol Cell Endocrinol | 2016 | https://conductscience.org/library/papers/26123589 | PubMed |
| 24820091 | NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma. | Thyroid | 2014 | https://conductscience.org/library/papers/24820091 | PubMed |
| 23933154 | Genetics and epigenetics of sporadic thyroid cancer. | Mol Cell Endocrinol | 2014 | https://conductscience.org/library/papers/23933154 | PubMed |
| 23873720 | RAS mutations in thyroid cancer. | Oncologist | 2013 | https://conductscience.org/library/papers/23873720 | PubMed |
| 22530151 | Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973-2007): race or shifting diagnostic paradigm? | ISRN Oncol | 2012 | https://conductscience.org/library/papers/22530151 | PubMed |
| 21603167 | Recent advances in molecular diagnosis of thyroid cancer. | J Thyroid Res | 2011 | https://conductscience.org/library/papers/21603167 | PubMed |
| 20001715 | Lessons from mouse models of thyroid cancer. | Thyroid | 2009 | https://conductscience.org/library/papers/20001715 | PubMed |
| 19358084 | Modeling thyroid cancer in the mouse. | Horm Metab Res | 2009 | https://conductscience.org/library/papers/19358084 | PubMed |
| 16785999 | Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. | Oncogene | 2006 | https://conductscience.org/library/papers/16785999 | PubMed |
| 15681856 | Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. | Endocr Pathol | 2004 | https://conductscience.org/library/papers/15681856 | PubMed |
| 12665646 | Molecular pathobiology of thyroid neoplasms. | Endocr Pathol | 2002 | https://conductscience.org/library/papers/12665646 | PubMed |
| 11704987 | Thyrotropin receptor mutations in thyroid diseases. | Rev Endocr Metab Disord | 2000 | https://conductscience.org/library/papers/11704987 | PubMed |
| 11126359 | The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. | Oncogene | 2000 | https://conductscience.org/library/papers/11126359 | PubMed |
| 10934169 | Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10934169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8552381
GET https://conductscience.org/api/papers/v1/8552381/authors